BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5172114)

  • 1. Uptake of drug-resistant tumour cell fractions by drug-sensitive tumour cells.
    Ujhăzy V; Kuzela S; Krempasky V; Bohunickă E
    Neoplasma; 1971; 18(6):627-30. PubMed ID: 5172114
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the tumor-inhibiting effect of ground substance particles. VII. Effect of glucosamine on the Budapest lymphosarcoma-mouse ascites tumor].
    Becker K; Voss H; Lindner J
    Arch Geschwulstforsch; 1964; 22(4):297-306. PubMed ID: 5896909
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of transplantable tumour cells by tetanus spores.
    Schneeweiss U; Fabricius EM
    Arch Geschwulstforsch; 1970; 35(1):1-5. PubMed ID: 4327129
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytochemical characterization of Yoshida sarcoma cells resistant to dibromodulcitol.
    Gáti E; Pokorny E; Somfai-Relle S; Szentirmay Z
    Int J Tissue React; 1984; 6(1):43-51. PubMed ID: 6715118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of amino acid incorporation by mitochondria isolated from Ehrlich ascites tumour cells to the in vivo treatment with 5-fluorouracil.
    Kuzela S; Krempaský V; Bohunická E; Ujházy V
    Neoplasma; 1972; 19(1):99-101. PubMed ID: 5012854
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enzyme therapy of neoplasms].
    Berezov TT
    Vestn Akad Med Nauk SSSR; 1971; 26(11):35-46. PubMed ID: 4330950
    [No Abstract]   [Full Text] [Related]  

  • 7. 51 Cr-L-asparagine accumulation by tumors: the influence of L-asparaginase treatment.
    Anghileri LJ
    J Nucl Biol Med; 1970; 14(4):150-2. PubMed ID: 5538035
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytoplasmic inheritance in metazoa and its relationship to cell phenotype. 3. Uptake of mouse liver cell fractions by 6C3HED lymphosarcoma cells in vitro.
    Whisson ME; Ujházy V; Krempaský V; Bouhunická E
    Neoplasma; 1970; 17(6):579-86. PubMed ID: 5537351
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of proteins and glycoproteins in tumour bearing mice treated with Aeromonas L-asparaginase.
    Benny PJ; Muraleedhara KG; Sreejith K; Jayashree G
    Indian J Biochem Biophys; 1996 Dec; 33(6):527-30. PubMed ID: 9219441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation kinetics of tumor and host cells after chemotherapeutic treatment.
    Takemitsu A
    Nagoya J Med Sci; 1975 Mar; 37(3-4):59-70. PubMed ID: 1160987
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxygen cytotoxicity in tumour cells.
    Bozzi A; Mavelli I; Mondovi B; Strom R; Rotilio G
    Bull Eur Physiopathol Respir; 1981; 17 Suppl():267-71. PubMed ID: 7248576
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
    Charles LM; Bono VH
    Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of biopreparation cACPL on the proliferative activity of haemopoietic and tumour cells.
    Jurásková V
    Folia Biol (Praha); 1988; 34(3):192-201. PubMed ID: 3203819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro studies using E. coli L-asparaginase on lymphatic cells of bovine leukemia and various transplantation tumors].
    Hirschmann WD; Seeber S; Warnecke P
    Klin Wochenschr; 1969 Nov; 47(22):1217-20. PubMed ID: 4909985
    [No Abstract]   [Full Text] [Related]  

  • 15. [Case of reticulum cell sarcoma treated with L-asparaginase and antibody to L-asparaginase].
    Ueda E; Yagura T; Tsubura E; Yamamura Y
    Gan No Rinsho; 1970 Nov; 16(11):1122-7. PubMed ID: 4922050
    [No Abstract]   [Full Text] [Related]  

  • 16. A new antitumour agent: phenazathionium-mustard salt.
    Csaba G; Körösi J
    Neoplasma; 1968; 15(4):443-5. PubMed ID: 5684468
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the activation of a cytostatic agent (cyclophosphamide-endoxan) by means of ionizing rays. II: The possibility of the use of irradiated endoxan in the therapy of malignant diseases].
    Tachiiri H; Gamo T; Yoshimura S; Shigematsu Y; Hara K; Yoshii G; Iwo K
    Strahlentherapie; 1968 Aug; 136(2):241-9. PubMed ID: 5684526
    [No Abstract]   [Full Text] [Related]  

  • 18. Chromosomal analysis on Yoshida tumor cells sensitive and resistant to dibromodulcitol.
    Gáti E
    Neoplasma; 1979; 26(1):79-83. PubMed ID: 431758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Absorption in vitro, by malignant cells, of serum proteins of rabbits and agoutis (l-asparaginase) conjugated with fluorescent substances].
    Wanick LR
    Rev Inst Antibiot (Recife); 1971 Jun; 11(1):39-42. PubMed ID: 5161610
    [No Abstract]   [Full Text] [Related]  

  • 20. [Additional classes of tumor inhibiting compounds. V. Cytostatic properties of alkylated alcohols and aldehydes of the chain length C 8 ].
    Weitzel G; Jackisch R; Meier-Gerwert H; Zinser D
    Hoppe Seylers Z Physiol Chem; 1972 Apr; 353(4):641-53. PubMed ID: 5053443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.